Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

autologous pancreatic adenocarcinoma lysate- and mRNA-loaded dendritic cell vaccine

A cell-based cancer vaccine composed of autologous dendritic cells (DCs) loaded with pancreatic adenocarcinoma lysate and mRNA containing and encoding tumor associated antigens (TAAs), with potential immunostimulatory and antineoplastic activities. Upon administration by perinodal injection using ultrasound guidance, the autologous pancreatic adenocarcinoma lysate and mRNA-loaded DC vaccine may stimulate an anti-tumoral cytotoxic T-lymphocyte (CTL) response against tumor cells expressing the patient's tumor cell-specific TAAs, which may result in tumor cell lysis.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:autologous pancreatic adenocarcinoma lysate and mRNA-loaded DCs
autologous pancreatic adenocarcinoma lysate and mRNA-loaded dendritic cells
autologous pancreatic adenocarcinoma lysate- and mRNA-loaded DC vaccine
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search